.png)
Attendees
-
CEO
-
CTO
-
CSO
-
CMO
-
Director
-
Vice President
-
Divisional Heads
-
Managers
-
Executives
-
ETC
Previous GDDIF Attendees Include:
AB Science
Almirall, S.A
Amgen
Angelini
Arvinas
Astex Pharmaceuticals
AstraZeneca
Bayer
Bicycle Therapeutics
Boehringer Ingelheim
Bristol Myers Squibb
Byondis
Carbon Logic Biotech
Centogene
Centre for Drug Design and Discovery (CD3)
Charles River Laboratories
Charm Therapeutics
Confo Therapeutics
Crescendo Biologics
Eisai
EMBL-EBI
Evox Therapeutics
Fierce Unicorn
Fisher Friedman IP Group
Freie Universitat Berlin
Galapagos NV
Genmab
Genome Biologics
Gilead Sciences
GlaxoSmithKline
Goethe-Universitat Hospital
Heath Innovation Research Alliance Northern Ireland
Hubrecht Organoid Technology
IRCCS San Raffaele
Janssen (Johnson & Johnson)
Laudea Research GmbH
Leibniz Institute for Farm Animal Biology
Leibniz Institute for Molecular Pharmacology (FMP)
Leiden University
LEO Pharma
Lhasa Limited
Lonza
Lygature
Max Delbruck Center
Max Planck Institute
Medibiofarma S.L.
Merck Group
Merck Sharp & Dohme (MSD)
Neurocrine Biosciences
Novartis
Parkinson's UK
Pfizer
Pharmablock
Radboud University Nijmegen
Roche
Sosei Heptares
Storm Therapeutics
Symeres
Technische Universitat Berlin
Tehran Polytechnic
TroplQ Health Sciences
Univercity Medicine Berlin
University of Groningen
University of Jerusalem
Vertex Pharmaceuticals
-
Medicinal Chemistry
-
CRO
-
CDMO
-
Research and Development,
-
Quantum Computing
-
New Drug Modalities
-
Collaborations / Business Development
-
Therapeutic Discovery
-
Advanced Therapies
-
Antibody Discovery
-
Biomarker Discovery
-
Screening ML / AI / LLM / Quantum / Digital
-
Biologics
-
R&D
-
Solution Architecture
-
Patient Engagement
-
Clinical Operations / Trials
-
Outsourcing
-
Digital Convergence
-
LLM, ELM, ML, AI
-
Data Management
-
Clinical Data
-
Computational Chemistry
-
Information Technology
-
Drug Design Cheminformatics
-
Bioinformatics
-
Automation
DDIF
